StockData
Turn Therapeutics Inc. logo

Turn Therapeutics Inc. (TTRX) stock

TTRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 2/30
$9.35−0.79 (-7.75%)

Close on Nov 13, 2026Market cap $278.37MP/E –Yield –

Turn Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Turn Therapeutics's total assets was $16.35M at Sep 30, 2026. For fiscal 2025 it was $12.16M, up 493.6% from the year before.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$12.16M+493.6%
FY2024Dec 31, 2024$2.05M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$16.35M+280.4%
Q2 FY2026Jun 30, 2026$16.96M+727.8%
Q1 FY2026Mar 31, 2026$18.64M–
Q4 FY2025Dec 31, 2025$12.16M–
Q3 FY2025Sep 30, 2025$4.30M–
Q4 FY2024Dec 31, 2024$2.05M–

More Turn Therapeutics figures

See a number that looks wrong?